Biomedical Translation Research Center, Academia Sinica, Taipei, Taiwan, 155.
Genomics Research Center, Academia Sinica, 128 Academia Rd., Sec.2, Nankang Dist., Taipei, Taiwan, 115.
Sci Rep. 2022 Jul 22;12(1):12555. doi: 10.1038/s41598-022-16841-9.
Antibodies recognize protein antigens with exquisite specificity in a complex aqueous environment, where interfacial waters are an integral part of the antibody-protein complex interfaces. In this work, we elucidate, with computational analyses, the principles governing the antibodies' specificity and affinity towards their cognate protein antigens in the presence of explicit interfacial waters. Experimentally, in four model antibody-protein complexes, we compared the contributions of the interaction types in antibody-protein antigen complex interfaces with the antibody variants selected from phage-displayed synthetic antibody libraries. Evidently, the specific interactions involving a subset of aromatic CDR (complementarity determining region) residues largely form the predominant determinant underlying the specificity of the antibody-protein complexes in nature. The interfacial direct/water-mediated hydrogen bonds accompanying the CDR aromatic interactions are optimized locally but contribute little in determining the epitope location. The results provide insights into the phenomenon that natural antibodies with limited sequence and structural variations in an antibody repertoire can recognize seemingly unlimited protein antigens. Our work suggests guidelines in designing functional artificial antibody repertoires with practical applications in developing novel antibody-based therapeutics and diagnostics for treating and preventing human diseases.
抗体在复杂的水相环境中以极高的特异性识别蛋白质抗原,界面水是抗体-蛋白质复合物界面的组成部分。在这项工作中,我们通过计算分析阐明了在存在明确界面水的情况下,抗体对其同源蛋白质抗原的特异性和亲和力的控制原理。在四个模型抗体-蛋白质复合物的实验中,我们比较了来自噬菌体展示合成抗体文库的抗体变体在抗体-蛋白质抗原复合物界面中的相互作用类型的贡献。显然,涉及一组芳香 CDR(互补决定区)残基的特定相互作用在很大程度上构成了抗体-蛋白质复合物在自然界中特异性的主要决定因素。伴随 CDR 芳香相互作用的界面直接/水介导氢键在局部得到优化,但对确定表位位置的贡献很小。这些结果深入了解了这样一种现象,即在抗体库中具有有限序列和结构变化的天然抗体可以识别看似无限的蛋白质抗原。我们的工作为设计功能性人工抗体库提供了指导,这些抗体库在开发用于治疗和预防人类疾病的新型基于抗体的治疗和诊断方法方面具有实际应用。